More stories

  • in

    GM lowers 2025 guidance, citing up to $5 billion in tariff exposure

    GM on Thursday lowered its 2025 earnings guidance to include a possible $4 billion to $5 billion impact as a result of President Donald Trump’s auto tariffs.
    GM said its new guidance includes adjusted EBIT of between $10 billion and $12.5 billion, down from $13.7 billion to $15.7 billion.
    GM released first quarter results Tuesday that beat Wall Street’s expectations but delayed its investor call and updated guidance details amid expected changes to the auto tariffs.

    DETROIT – General Motors on Thursday lowered its 2025 earnings guidance to include a possible $4 billion to $5 billion impact as a result of President Donald Trump’s auto tariffs.
    The Detroit automaker said its new guidance includes adjusted earnings before interest and taxes of between $10 billion and $12.5 billion. That compares with its former guidance, which did not take tariffs into account, of $13.7 billion to $15.7 billion.

    GM’s 2025 guidance also includes net income attributable to stockholders of $8.2 billion to $10.1 billion, down from $11.2 billion to $12.5 billion and adjusted automotive free cash flow of between $7.5 billion and $10 billion, down from $11 billion to $13 billion. The company did not change its capital spending target of between $10 billion and $11 billion.
    “Importantly, GM’s business is growing and fundamentally strong as we adapt to the new trade policy environment, further strengthen our supply base, and drive EV profitability,” GM CEO Mary Barra said in a shareholder letter on Thursday.

    The guidance takes into account “the positive impact” of the Trump administration’s changes this week to some tariffs that include reimbursing automakers for some U.S. parts and reducing the “stacking” of tariffs upon each other for the industry.
    GM released first quarter results Tuesday that beat Wall Street’s expectations but delayed its investor call and updated guidance details amid expected changes to the auto tariffs.
    Barra on Thursday told CNBC’s Phil LeBeau that the company is working to offset as much of the increased costs from tariffs as possible.
    “Absolutely, we can make changes. We’ve been working on our supply chain since 2019, to be more resilient,” Barra said, citing a 27% increase in U.S. sourced parts. “We have a lot of opportunity as we continue to work with our supply base to increase the U.S. content. You’ll see more announcements from us now that we actually have this clarity to be able to reinvest in the U.S.”
    Barra declined to say whether the company would shift production from plants in Mexico to the U.S. She said the company will utilize its current assets. That includes 11 large assembly plants in the U.S. that employ tens of thousands of workers.
    “We’re going to leverage that footprint that we have because we have the ability to add capacity to many of those plants. So we can do this efficiently, and it’s going to allow us to do this more quickly than if we were going to start with a greenfield,” Barra said. More

  • in

    CVS tops estimates, hikes guidance as insurance business shows some improvement

    CVS Health reported first-quarter revenue and profit that topped estimates and hiked its guidance, as its troubled insurance business showed some improvement during the period. 
    The company now expects full-year adjusted earnings of $6 to $6.20 per share, up from a previous guidance of $5.75 to $6 per share.
    Still, CVS said it is “maintaining a cautious view for the remainder of the year” in light of continued higher medical costs and “the potential for macro headwinds.”

    CVS Pharmacy logo is seen in Washington DC, United States on July 9, 2024.
    Jakub Porzycki | Nurphoto | Getty Images

    CVS Health on Thursday reported first-quarter earnings and revenue that topped estimates and hiked its guidance, as its troubled insurance business showed some improvement during the period. 
    Shares of CVS were up 7% in premarket trading Thursday.

    The company now expects full-year adjusted earnings of $6 to $6.20 per share, up from a previous guidance of $5.75 to $6 per share.
    But the company revised its GAAP diluted EPS guidance to be lower, which includes charges related to a legal battle involving its pharmacy services provider subsidiary, Omnicare. A jury this week found Omnicare liable for dispensing drugs without valid prescriptions to elderly and disabled individuals in assisted living and long-term care facilities. CVS plans to appeal.
    The company did not provide a revenue forecast for the year. CVS said it is “maintaining a cautious view for the remainder of the year” in light of continued higher medical costs and “the potential for macro headwinds.”
    “We got smarter about the markets that we wanted and the lives that we wanted to compete for, and so we actually have planned and budgeted for the elevated trends,” CVS CEO David Joyner said in an interview with CNBC, referring to markets that the insurance unit operates in and higher medical costs
    “So I think why you’re not seeing a surprise on our part is because we actually plan for elevated trends going into this year,” he added.

    Joyner said the company is watching for the potential impact from President Donald Trump’s planned tariffs on pharmaceuticals imported into the U.S.
    “On the pharmacy side, I think it is highly dependent on what happens in the next week or two when they announce the implications of tariffs on the manufacturers,” he told CNBC. Joyner added that the vast majority of the company’s retail products at the front of stores are sourced in the U.S., “which should be a benefit for us.”
    Here’s what CVS reported for the first quarter compared with what Wall Street was expecting, based on a survey of analysts by LSEG: 

    Earnings per share: $2.25 per share adjusted vs. $1.70 per share expected
    Revenue: $94.59 billion vs. $93.64 billion expected

    The company’s insurer, Aetna, and its rivals have been dogged by higher-than-expected medical costs over the last year as more Medicare Advantage patients return to hospitals for procedures they delayed during the pandemic. But for the first time in several quarters, CVS’ insurance business appeared to show some signs of improvement.
    The unit’s medical benefit ratio — a measure of total medical expenses paid relative to premiums collected — decreased to 87.3% from 90.4% a year earlier. A lower ratio typically indicates that a company collected more in premiums than it paid out in benefits, resulting in higher profitability.
    CVS said the move partly reflects stronger underlying performance in its Medicare business and improved Medicare Advantage star ratings for the 2025 payment year. Those ratings help patients compare the quality of Medicare health and drug plans.
    “I think that investment and talent that allowed us to focus on both the execution and the operation … actually helped establish the performance that you’re seeing,” Joyner said, referring to an executive reshuffling last year that tapped a new leader for the insurance unit and other parts of the business.
    The results cap off the second full quarter with Joyner, a longtime CVS executive, as chief executive of the retail drugstore chain. Joyner succeeded Karen Lynch in mid-October, as CVS struggled to drive higher profits and improve its stock performance.
    The company underwent a management reshuffle as part of a broader turnaround plan that includes $2 billion in cost cuts over the next several years.
    Still, CVS’ performance was partially offset by a charge of $431 million from so-called premium deficiency reserves in the insurance unit, which is related to anticipated losses in the 2025 coverage year. That refers to a liability that an insurer may need to cover if future premiums are not enough to pay for anticipated claims and expenses.
    The company posted net income of $1.78 billion, or $1.41 per share, for the first quarter. That compares with net income of $1.12 billion, or 88 cents per share, for the year-earlier period. 
    Excluding certain items, such as amortization of intangible assets, restructuring charges and capital losses, adjusted earnings were $2.25 per share for the quarter.
    CVS booked sales of $94.59 billion for the first quarter, up 7% from the same period a year ago due to growth across all three of its business segments. 
    But sales in the company’s retail pharmacy segment missed Wall Street’s expectations for the quarter, according to StreetAccount. That business has been pressured by softer consumer spending and lower reimbursements for prescription drugs. 

    Strength across business units

    CVS’ insurance business booked $34.81 billion in revenue during the quarter, up 8% from the first quarter of 2024. Analysts expected the unit to take in $33.51 billion for the period, according to estimates from StreetAccount.
    The unit also recorded adjusted operating income of $1.99 billion for the first quarter, compared with $732 million for the year-earlier period. 
    Also on Thursday, CVS said Aetna will stop offering health insurance plans on the Affordable Care Act marketplaces — also known as individual exchanges — starting in the 2026 plan year.

    More CNBC health coverage

    CVS’ pharmacy and consumer wellness division booked $31.91 billion in sales for the first quarter, up more than 11% from the same period a year earlier.
    But that was far under the $35.27 billion that analysts were expecting for the quarter, according to StreetAccount.
    That unit dispenses prescriptions in CVS’ more than 9,000 retail pharmacies and provides other pharmacy services, such as vaccinations and diagnostic testing.
    CVS’ health services segment generated $43.46 billion in revenue for the quarter, up nearly 8% compared with the same quarter in 2024. Analysts expected the unit to post $43.64 billion in sales for the period, according to StreetAccount.
    That unit includes Caremark, one of the nation’s largest pharmacy benefit managers. Caremark negotiates drug discounts with manufacturers on behalf of insurance plans and creates lists of medications, or formularies, that are covered by insurance and reimburses pharmacies for prescriptions.

    Don’t miss these insights from CNBC PRO More

  • in

    How wealthy horse owners finance their passion and potentially earn millions

    Race horses are regarded as a passion asset like fine art or wine, but come with unique challenges.
    They are pricey investments that require commitment as they can live as long as 30 years.
    Bank of America’s Steven Mason told CNBC why wealthy horse owners take out loans and how they plan for their kids’ inheritances.

    Mystik Dan #3, ridden by jockey Brian J. Hernandez Jr. (R), crosses the finish line ahead of Sierra Leone #2, ridden by jockey Tyler Gaffalione and Forever Young, ridden by jockey Ryusei Sakai to win the 150th running of the Kentucky Derby at Churchill Downs on May 04, 2024 in Louisville, Kentucky. 
    Michael Reaves | Getty Images

    This Saturday marks the 151st Kentucky Derby. The winner will earn $3.1 million from a purse of $5 million divided among the top five finishers.
    Bank of America’s Steven Mason will be at the finish line, watching from a box along with his high-net-worth clients. Based in Nashville, Tennessee, the private banker has specialized in equestrian clients for nearly a decade. It came naturally to Mason, who grew up in Kentucky and bought a small horse farm for his two daughters when he moved to Nashville.

    “Horses are a lifestyle,” the senior vice president said of his clients. “In some respects, they think of them as investments, and some of it, they think they are just an extension of who they are.”
    Mason cautioned that horses, like other passion assets, are illiquid investments with uncertain returns.
    “I think you have to look at it like there may be a return or there may not be a return, but I’m going to have a really good time while I’m pursuing wherever this goes,” he said.
    While many of his clients grew up with horses, he has seen an increasing number of entrepreneurs become first-time horse owners after a liquidity event. More hedge fund managers are entering the arena, such as former hedge funder Jack Wolf, who co-owns Justify, the last horse to win the Triple Crown.

    Get Inside Wealth directly to your inbox

    Mason’s tax-savvy clients typically take out loans to purchase horses rather than liquidating their assets, which would incur capital gains taxes. However, unlike with other specialized assets such as yachts and jets, Bank of America doesn’t allow clients to use horses as collateral. 

    “Banks don’t have an appetite to have a breathing, living animal as collateral,” Mason said. “God forbid something happened to the horse. Then you’re left with an uncollateralized loan.”
    Clients typically take out a private credit line secured by marketable securities with a floating interest rate. This rate is based on a popular loan benchmark called the secured overnight financing rate (SOFR), which has averaged 4.35% the past 30 days, plus a spread determined by the bank.

    Steve Mason (right) pictured with his son John Michael, wife Amy-Beth and daughter Clare at the 2024 Iroquois Steeplechase in Nashville, Tennessee.
    Courtesy of Steve Mason

    For owners of successful race horses, stud fees are far more lucrative than track winnings. Stud fees for top race horses can top $300,000, though most are much lower, according to Mason. Most are bred to 30 or 40 mares per season, he said.
    There is robust demand for high-end race horses even though the sport has declined in popularity. Mason noted demand for yearlings, or young horses, is especially strong, which he credits to the increasing popularity of horse racing syndicates. Auction house Keeneland’s September yearling sale generated a record $428 million last year. The average selling price per horse was $150,548 up 5.2% year over year, according to Keeneland.
    The finest thoroughbreds, such as those at Fasig-Tipton’s annual November sale, can fetch seven figures at auction.

    While race horses can have shorter lifespans due to injuries, the average lifespan for horses is 25 to 30 years. Caring for a thoroughbred is pricey, costing up to $60,000 a year, according to Mason. To clients afraid of saddling their kids with an expensive burden, Mason recommends funding a trust that provides for the horse’s care. 
    For Mason, working with equestrians is not only a calling card but also a way to earn client loyalty.
    “When we can stand shoulder to shoulder with a client and talk with them about their particular situation in our office or out on a farm or at a horse arena, it just really makes that relationship all the more special and all the more close knit,” he said. More

  • in

    Can Starbucks be turned around?

    Investors cheered when Brian Niccol was named chief executive of Starbucks last August. Mr Niccol, then the boss of Chipotle, a Mexican-restaurant group, had earned an almost messianic reputation for turning around struggling hospitality businesses. The world’s biggest coffee chain, increasingly derided for its tired stores, slow service and pricey brews, desperately needed such a saviour. More

  • in

    Ford CEO says Trump’s tariff reprieve is helpful, but more changes needed

    Ford CEO Jim Farley said President Donald Trump’s executive order softening some of the automotive tariffs was helpful, but there still need to be more changes.
    Farley said the auto industry still needs “a comprehensive set of policies.”
    It’s “essential” for U.S. policies to encourage exports as well as reward companies for their American production, the CEO said.

    Ford Motor CEO Jim Farley speaks during a launch event for the 2025 Ford Expedition in Louisville, Kentucky, on April 30, 2025.
    Michael Wayland | CNBC

    LOUISVILLE, Ky. – President Donald Trump’s reprieve for automotive parts tariffs is helpful, but more changes are still needed to assist automakers and grow the U.S. auto industry, Ford Motor CEO Jim Farley said Wednesday.
    The new actions — which Trump signed into action via an executive order Tuesday — reimburse automakers for some U.S. parts and reduce the “stacking” of tariffs upon each other for the industry.

    Tuesday’s changes came after pleas from the automotive industry for relief amid regulatory uncertainty around Trump’s tariffs, including 25% on imported vehicles into the U.S. and an upcoming 25% on automotive parts by May 3.
    “The changes this week on tariff plans will help ease impact on tariffs for automakers, suppliers and consumers, but … we need to continue to work closely with the administration on a comprehensive set of policies to support our shared vision of that healthy and growing auto industry, and we are not there yet,” Farley said during a launch event for the 2025 Ford Expedition at the company’s Kentucky Truck Plant.

    A worker at Ford’s Kentucky Truck Plant on April 30, 2025.
    Michael Wayland | CNBC

    Farley said it’s “essential” for U.S. policies to encourage exports as well as reward companies, such as Ford, for their American production.
    “So many of the vehicles we build here are exported around the globe. Shouldn’t we get credit for that?” Farley said. “Those are American jobs and we have to keep working on affordable parts to ensure that those supply chains promote domestic growth and affordable vehicles in our country.”
    Ford, which is the largest producer of vehicles in the U.S., says it is a net exporter of parts and vehicles based on total value of goods, and nearly a net exporter on a per vehicle basis. A net exporter means a company exports more than it imports.

    Read more CNBC tariffs coverage

    Farley laid out a number of “what if” scenarios regarding the impact to the U.S. auto industry and America if competitors matched Ford’s manufacturing operations. He said such actions would mean an increase of 4 million vehicles per year, 15 new manufacturing plants and more than 500,000 new manufacturing jobs in the U.S.
    “Imagine if the companies who import all the vehicles in the U.S. treated American manufacturing like Ford,” said Farley, whose company still imports a notable amount of vehicles and parts from Mexico, Canada and China.
    Tariffs of 25% on imported vehicles into the U.S. will continue, but the new measures aim to reduce the overall tariff level that had resulted from separate levies — such as an additional 25% tariffs on steel and aluminum — “stacking” on top of one another.
    Under the order, additional 25% tariffs on auto parts that were set to start by May 3 will also still take effect, but vehicles that go through final assembly in the U.S. will be able to qualify for partial reimbursements on those levies for two years.

    Don’t miss these insights from CNBC PRO More

  • in

    RFK Jr. is gutting minority health offices across HHS that are key to reducing health disparities

    Robert F. Kennedy Jr.’s overhaul of the Department of Health and Human Services involves deep cuts to several divisions that help protect and improve the health of minority and underserved populations and eliminate health disparities in the U.S., CNBC has learned.
    Kennedy’s cuts have hit at least seven minority health offices across HHS, which in many cases laid off most or all of their workers, including directors, people familiar with the matter told CNBC.
    Health policy experts said deep cuts to those offices could widen existing disparities in access to insurance and care in the U.S., undoing years of progress toward addressing them.

    Employees of the Department of Health and Human Services (HHS) queue outside the Mary E. Switzer Memorial Building, after it was reported that the Trump administration fired staff at the Centers for Disease Control and Prevention and at the Food and Drug Administration, as it embarked on its plan to cut 10,000 jobs at HHS, in Washington, D.C., U.S., April 1, 2025.
    Kevin Lamarque | Reuters

    Robert F. Kennedy Jr.’s overhaul of the Department of Health and Human Services involves deep cuts to several divisions that help protect and improve the health of minority and underserved populations and eliminate health disparities in the U.S., CNBC has learned.
    Kennedy, the Health and Human Services secretary, has gutted at least seven minority health offices across the department, according to people familiar with the matter, who requested anonymity to speak freely. HHS has laid off a significant share of workers at those offices, or in some cases all of them, along with their directors, the people said.

    The affected units include the HHS Office of Minority Health and the National Institute on Minority Health and Health Disparities, or NIMHD. The cuts also hit offices with similar functions at the Food and Drug Administration, the Centers for Disease Control and Prevention, the Centers for Medicare & Medicaid Services, the Health Resources and Services Administration, and the Substance Abuse and Mental Health Services Administration, according to the people. 
    Health policy experts told CNBC that deep cuts to those divisions could widen existing health disparities in the U.S., undoing years of progress toward addressing them. Over time, that could worsen health outcomes for already underserved groups, threaten overall public health, strain the U.S. health-care system and drive up health-care costs. 
    “It will have negative health impacts, obviously, for groups that they’re focused on, so racial and ethnic minorities, but I think what gets missed in the story is it ultimately impacts all of us, no matter what your background is,” Dr. Stephanie Ettinger De Cuba, research professor of health law, policy and management at Boston University, told CNBC. 
    “It’s not a zero-sum game. So I think that’s what is deeply disturbing to me, as we are going to see people get hurt,” she said. “Decimating or cutting staff from these offices ultimately makes it worse for everyone.”
    The Trump administration can’t shutter the affected offices entirely, which would be against the law since they were authorized by the Affordable Care Act more than a decade ago, the people said. The exact fate of each office and the NIH institute is unclear, they added. 

    The administration likely hopes to at least “narrow the scope” of what NIMHD and the agency offices do, curtailing their authority and limiting resources, said Brandyn Churchill, professor of public administration and policy at American University. 
    The cuts come as health disparities remain a major challenge in the U.S., affecting not only people of color but also rural residents, low-income communities and individuals with disabilities, among several other groups. These communities often face worse health outcomes – such as lower life expectancy and higher rates of infant mortality and chronic disease – and more limited access to care and other resources than the U.S. population as a whole. 
    The Covid-19 pandemic deepened many of these gaps, highlighting how the long U.S. history of exclusionary policies and systemic issues such as poverty and racism contribute to unequal health outcomes across the country. 
    Health policy experts stress that addressing those disparities leads to stronger overall public health, as healthier communities improve outcomes for everyone. It could also relieve a huge economic burden on the U.S: a 2023 study funded by NIMHD found that racial and ethnic health disparities cost the U.S. economy $451 billion in 2018.  

    U.S. Health and Human Services Secretary Robert F. Kennedy Jr. delivers remarks during a Cabinet meeting held by President Donald Trump at the White House on Feb. 26, 2025 in Washington, DC.
    Andrew Harnik | Getty Images

    Kennedy is consolidating divisions and slashing 10,000 jobs at HHS, a $1.7 trillion agency that oversees vaccines and other medicines, scientific research, public health infrastructure, pandemic preparedness, and food and tobacco products. HHS also manages government-funded health care for millions of Americans – including seniors, disabled people and lower-income patients who rely on Medicare, Medicaid and the Affordable Care Act’s markets.
    Kennedy plans to create a new HHS agency called the Administration for a Healthy America, which will combine several existing offices. That includes HRSA, SAMHSA, the Office of the Assistant Secretary for Health, the Agency for Toxic Substances and Disease Registry, and the National Institute for Occupational Safety and Health.
    A leaked 64-page preliminary budget document also indicates that the HHS Office of Minority Health would fall under that new agency, according to several reports. But that proposal, which would slash the HHS budget by a third, or roughly $40 billion, requires congressional approval. 
    HHS did not immediately respond to a request for comment.

    How RKF Jr. gutted minority health offices

    While the breadth of the cutbacks varied at agencies within HHS, the minority health agencies across the departments will now be only a fraction of their former size.
    All 40 staff members at the CMS Office of Minority Health were laid off, according to the people. CMS plans to appoint a new director for that unit, but the current director has not resigned from the role, CNBC previously reported.
    The office works with local and federal partners to eliminate disparities in health coverage, aiming to ensure that minority and underserved populations can access Medicare, Medicaid and Affordable Care Act marketplace plans. It also conducts research and analysis to help lower costs and reduce the incidence and severity of chronic diseases in the U.S. 

    An aerial of the Centers for Medicare & Medicaid Services building on March 19, 2025 in Woodlawn, Maryland. 
    Kayla Bartkowski | Getty Images

    Nearly all staff at the CDC’s Office of Minority Health were cut, according to the people. To adhere to the letter of the law, the Trump administration is considering reconstituting that unit and the Office of Women’s Health so that each office would be made up of at least one director or a very small group of employees, the people said. 
    The agency’s Office of Minority Health works across CDC to promote research of health disparities and create programs to improve the health of racial and ethnic minority groups.
    At the FDA’s Office of Minority Health and Health Equity, all staff were cut, the people said. The future of that office is unclear. 
    The unit focuses on efforts such as increasing clinical trial diversity, improving transparency around how medical products affect different populations, and creating health resources tailored to a range of languages and cultures.
    No staff are left at HRSA’s Office of Health Equity after the layoffs, as well as some retirements and reassignments, according to the people. That office leads efforts to reduce disparities in health-care access, quality and outcomes through HRSA, which focuses on people who are uninsured, geographically isolated, or economically and medically vulnerable.
    The future of that office is also unclear, apart from the Trump administration’s plans to fold HRSA into Kennedy’s new agency.
    The same goes for SAMHSA’s Office of Behavioral Health Equity, which saw all remaining staff cut except for a new, recently hired director, according to the people. The office also had a retirement and one worker on probation who was put on administrative leave. 
    The office works to ensure that SAMHSA’s resources for mental health and substance abuse treatment, including grant programs and other initiatives, are equitably distributed across all communities and populations.
    Roughly a third of staff are gone at NIMHD, some of whom were laid off and others who left due to early retirements and buyouts, the people said. Some workers on probation were put on leave several weeks before Kennedy started cuts, they said. 
    The institute’s deputy director accepted an offer to be acting director in the short term, the people added. NIMHD, which is part of the National Institutes of Health, works to reduce health disparities through conducting and funding research and developing new programs.
    The HHS Office of Minority Health also faced cuts, though it’s unclear how many staff were impacted, the people said. That office leads the federal effort to improve health outcomes for racial and ethnic minority groups, developing policies and programs and providing funding.

    Cuts could have lasting effects

    It will likely take several months to a year before the U.S. sees direct consequences from the cuts to NIMHD and the offices, said Terry McGovern, professor at the CUNY Graduate School of Public Health and Health Policy.

    Employees of the Department of Health and Human Services (HHS) stand outside the Mary E. Switzer Memorial Building, after it was reported that the Trump administration fired staff at the Centers for Disease Control and Prevention and at the Food and Drug Administration, as it embarked on its plan to cut 10,000 jobs at HHS, in Washington, D.C., U.S., April 1, 2025. 
    Kevin Lamarque | Reuters

    But the staff reductions could cause the U.S. to lose out on crucial data, which is the cornerstone for addressing health disparities, according to Samantha Artiga, director for the racial equity and health policy program at KFF, a health policy research organization. 
    Artiga said data and research are essential for pinpointing where disparities exist, understanding their root causes, crafting effective solutions, and tracking progress over time. For example, data can reveal whether certain groups experience worse surgical outcomes or wait longer at the emergency room, or if a vaccination program is being equitably distributed across regions.
    “Without focused data and research, those disparities may remain unseen and unaddressed, creating blind spots,” Artiga said, adding that the U.S. would eventually have to rebuild that knowledge in the future. 
    The fate of many of the grants that NIMHD and some of the offices provide is unclear. That includes $11.6 million in recent grant awards from HHS’ Office of Minority Health to 20 organizations for a four-year initiative to identify strategies that increase the use of preventive health services in communities. 
    But if offices cut back that funding or stop it altogether, it could also weaken the nation’s ability to reduce health disparities, Boston University’s Ettinger De Cuba said. 
    Community-based organizations rely on federal money to deliver culturally tailored care to different groups, and could be forced to scale back or shut down programs. The loss of grants could also stall research, innovation and public health interventions by outside entities, such as universities, health-care systems and social service organizations. 
    “Philanthropy is not able to step up at this level long term. The only actor that’s able to do that is the government,” Ettinger De Cuba said. 

    More CNBC health coverage

    Nathan Boucher, research professor at Duke’s Sanford School of Public Policy, added that the cuts will “degrade any effort of these larger governmental organizations to have any accountability when it comes to protecting the people they help and serve every day.” 
    While Kennedy has said his cuts are focused on making HHS more “responsive and efficient,” Boucher said targeting minority health offices could do the opposite. 
    “I actually think it’s an efficiency argument to be able to have these minority health offices, because it allows you to identify and target some real problem areas and use taxpayer dollars in the most efficient way possible,” said Boucher.  More

  • in

    Can Shein and Temu survive Trump’s trade war?

    For Gen Z shoppers in America, Donald Trump’s trade war with China is no longer just a headline. On April 25th Shein and Temu, two Chinese online emporiums popular among youngsters, announced they would be adjusting their prices in America. The cost of some goods sold by Shein subsequently shot up by more than 150%. Temu has added “import charges” that in some cases exceed the price of the item being purchased. More

  • in

    Dollar General is one of the best stock performers of Trump’s first 100 days

    Dollar General has greatly outperformed the S&P 500 during President Donald Trump’s first 100 days back in office.
    Analysts say a market rotation to defensive stocks and Dollar General’s lower exposure to China tariffs have boosted the stock.
    Still, the dollar store’s shares are recovering from a steep plunge in August.

    The Dollar General in Snow Hill, Maryland on April 2, 2024.
    Deb Lindsey | The Washington Post | Getty Images

    Dollar General is among the best-performing stocks in the first 100 days of President Donald Trump’s second term.
    Since Trump’s Jan. 20 inauguration, shares of the discount retailer have soared more than 36% as of Tuesday’s close, the third-largest percentage-point rise in the S&P 500 behind software company Palantir and tobacco giant Philip Morris International. It’s far outperformed the consumer staples sector as a whole, which is up 6% since the inauguration as of end of trading Tuesday, and climbed higher than competitors like Dollar Tree and Walmart.

    Stock chart icon

    Chart comparing stock performances of Dollar General, Dollar Tree and Walmart since President Donald Trump’s Jan. 20 inauguration.

    Part of the story is an overall market rotation to defensive plays like consumer staples. Amid widespread economic uncertainty, especially around inflation and Trump’s tariffs, investors have pivoted from growth stories to safer harbors.
    “Historically, the dollar stores have done better in softer macro environments, especially if we were heading into a recession,” said CFRA Research senior vice president Arun Sundaram.
    Stocks plunged in early April when Trump announced steep “reciprocal tariffs” on dozens of trading partners, most of which he later lowered to a universal level of 10% for a period of 90 days.
    Dollar General stayed relatively resilient throughout the tariff turmoil and is up 5% in April, while the S&P 500 is still down more than 2% for the month.
    Dollar General is less exposed to tariffs than other companies, analysts told CNBC, because of its product mix. Only 4% of its purchases are imports, according to KeyBanc Capital Markets equity research analyst Bradley Thomas.

    The retailer makes most of its money from consumable products like food that are less vulnerable to duties than discretionary categories such as seasonal goods and home products, Sundaram said. Consumables accounted for 82.2% of Dollar General’s sales last year, compared with just 48.8% of sales at Dollar Tree.
    That mix reduces Dollar General’s reliance on Chinese imports, Sundaram said, which are currently taxed at an effective tariff rate of 145%. China and the U.S. have been in an apparent standoff in trade negotiations.
    Dollar General stock has also been recovering from a steep plunge in August after the company issued a disappointing earnings report and cut guidance for the year. Dollar General shares are still down more than 36% from their 52-week closing high, notched last May, and have fallen almost 65% from their all-time closing high from October 2022.
    “This is a stock that’s been beaten up pretty hard over the last several years,” Sundaram said.

    Stock chart icon

    Dollar General stock plunged in August 2024 and has been slowly recovering since then.

    Dollar General CEO Todd Vasos has been working on a turnaround since returning to the company in October 2023. A back-to-basics focus on productivity and existing stores has contributed to its recent success, said Telsey Advisory Group senior research analyst Joe Feldman.
    Analysts said the company continues to face stiff competition from retail giants like Walmart, Amazon and Costco. Those behemoths have more robust online presences that give them an edge over dollar stores, especially as Walmart’s e-commerce membership business, Walmart+, continues to grow.
    “Walmart is the big, 800-pound gorilla that Dollar General is up against,” Thomas said. “We see a risk that the dollar stores as a sector, more broadly, will be losing some traffic to the growing delivery business of Walmart+.”
    The macro outlook could also provide further headwinds, especially if Trump’s tariff pause lapses without trade deals. Tariff-driven inflation, as well as a potential expiration of Trump’s 2017 tax cuts and proposed changes to the Supplemental Nutrition Assistance Program, could place extra pressure on Dollar General’s lower-income base.
    The discounter has benefited from more middle-income “trade-down” shoppers, who could help offset losses from low-income customers, Feldman said, but its core customer is already stretching their dollar.
    “The demand is strong from their customer, but the ability to fulfill that demand is not as strong these days,” Feldman said. “That’s really their one issue to be watching here.” More